Voltron Therapeutics develops precision-guided, self-assembling vaccines for cancer and infectious diseases.
Voltron Therapeutics has raised $5.9M in total funding. The most recent round was Grant. The last funding was announced in August 2023.
Voltron Therapeutics's investors include U.S. Department of War.
Voltron Therapeutics is headquartered in New York, United States.
Voltron Therapeutics develops precision-guided, self-assembling vaccines for cancer and infectious diseases.
Voltron Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Voltron Therapeutics — Funding & Investors." VCBacked, August 17, 2023, https://www.vcbacked.co/company/voltron-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Voltron Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/voltron-therapeutics
{{cite web |title=Voltron Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/voltron-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated